Table of Content




1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary


2. Strategic Recommendations
2.1 Asia Pacific region to witness augmented growth in the forecast period.
2.2 Contribution in Research and Development activities to expand the overactive bladder treatment products.


3. Global Overactive Bladder Product Outlook


4. Global Overactive Bladder Treatment Market: An Analysis
4.1 Market Size, By Value, Year 2014-2024


5. Global Overactive Bladder Treatment Segmentation By Medication(By Value)
5.1 Competitive Scenario of Global Overactive Bladder Treatment Market – By Medication
5.2 Oxybutynin – Market Size and Forecast (2014-2024)
5.3 Tolterodine – Market Size and Forecast (2014-2024)
5.4 Tropism – Market Size and Forecast (2014-2024)
5.5 Solifenacin – Market Size and Forecast (2014-2024)
5.6 Mirabegron – Market Size and Forecast (2014-2024)
5.7 Others – Market Size and Forecast (2014-2024)


6. Global Overactive Bladder Treatment Market Segmentation By Therapy(By Value)
6.1 Competitive Scenario of Global Overactive bladder treatment: By Therapy
6.2 BOTOX– Market Size and Forecast (2014-2024)
6.3 SNM Therapy- Market Size and Forecast (2014-2024)
6.4 PTNS Therapy-Market Size and Forecast (2014-2024)


7. Global Overactive Bladder Treatment Market: Regional Analysis
7.1 Competitive Scenario of Global Overactive Bladder Treatment: By Region


8. North America Overactive Bladder Treatment Market: By Analysis
8.1 North America Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
8.2 Market Segmentation By Medication
8.3 Market Segmentation By Therapy
8.4 North America Global Overactive Bladder Treatment Market: Country Analysis
8.5 Market Opportunity Chart of North America Overactive Bladder treatment Market - By Country, By Value (Year-2024)
8.6 Competitive Scenario of North America Overactive Bladder treatment : By Country
8.7 United States Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
8.8 United States Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
8.9 Canada Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
8.10 Canada Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
8.11 Mexico Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
8.12 Mexico Overactive Bladder Treatment Market Segmentation By Medication, By Therapy


9. Europe Overactive Bladder Treatment Market: Segmentation By Medication, By Therapy (2014-2024)
9.1 Europe Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
9.2 Market Segmentation By Medication
9.3 Market Segmentation By Therapy
9.4 Europe Global Overactive Bladder Treatment Market: Country Analysis
9.5 Market Opportunity Chart of Europe Overactive Bladder treatment Market - By Country, By Value (Year-2024)
9.6 Competitive Scenario of Europe Overactive Bladder treatment : By Country
9.7 France Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
9.8 France Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
9.9 Germany Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
9.10 Germany Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
9.11 Italy Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
9.12 Italy Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
9.13 Spain Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
9.14 Spain Overactive Bladder Treatment Market Segmentation By Medication, By Therapy


10. APAC Overactive Bladder Treatment Market: Segmentation By Medication, By Therapy (2014-2024)
10.1 APAC Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
10.2 Market Segmentation By Medication
10.3 Market Segmentation By Therapy
10.4 APAC Global Overactive Bladder Treatment Market: Country Analysis
10.5 Market Opportunity Chart of APAC Overactive Bladder treatment Market - By Country, By Value (Year-2024)
10.6 Competitive Scenario of APAC Overactive Bladder treatment : By Country
10.7 India Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
10.8 India Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
10.9 China Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
10.10 China Overactive Bladder Treatment Market Segmentation By Medication, By Therapy
10.11 Japan Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
10.12 Japan Overactive Bladder Treatment Market Segmentation By Medication, By Therapy


11. ROW Overactive Bladder Treatment Market: Segmentation By Medication, By Therapy (2014-2024)
11.1 ROW Overactive Bladder Treatment Market: Size and Forecast (2014-2024)
11.2 Market Segmentation By Medication
11.3 Market Segmentation By Therapy


12. Global Overactive Bladder Treatment Market Dynamics
12.1 Global Overactive Bladder Treatment Market Drivers
12.2 Global Overactive Bladder Treatment Market Restraints
12.3 Global Overactive Bladder Treatment Market Trends


13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness
13.2 Market Attractiveness Chart of Global Overactive Bladder Treatment Market - By Medication (Year 2024)
13.3 Market Attractiveness Chart of Global Overactive Bladder Treatment Market - By Therapy (Year-2024)
13.4 Market Attractiveness Chart of Global Overactive Bladder Treatment Market - By Region, By Value, (Year-2024)


14. Pipeline Product Analysis
14.1 New Technologies in Overactive Bladder Treatments
14.2 Key Pipeline Drugs in Overactive Bladder Treatment Market
14.3 Key new operative therapies in Overactive Bladder Treatment Market


15. Competitive Landscape
15.1 Market Share Analysis
15.2 SWOT Analysis
15.3 Porter’s Five Force Analysis


16. Company Profiles (Business Description, Financial Analysis, Business Strategy)
16.1 Astellas Pharma Inc.
16.2 Allergan
16.3 Pfizer Inc.
16.4 Laborie
16.5 Teva Pharmaceutical
16.6 Intas Pharmaceutical Ltd.
16.7 Axonics Modulation Technologies, Inc.
16.8 Apotex
16.9 Macleods Pharmaceuticals Ltd.
16.10 Sanofi S.A.